New conformationally locked bicyclic N,O-nucleoside analogues of antiviral drugs.

Bioorg Med Chem Lett

Dipartimento di Scienze Farmaco-Biologiche, Università della Magna Graecia, Complesso Niní Barbieri, 88021 Roccelletta di Borgia (Cz), Italy.

Published: February 2005

In order to obtain rigidity within the sugar moiety of nucleosides, the bicyclic pyrimidine derivatives of N,O-isoxazolidines were designed and synthesized by using 1,3-dipolar cycloaddition of Delta(1)-pyrrolidine-1-oxide and the appropriate vinyl-nucleobases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2004.11.048DOI Listing

Publication Analysis

Top Keywords

conformationally locked
4
locked bicyclic
4
bicyclic no-nucleoside
4
no-nucleoside analogues
4
analogues antiviral
4
antiviral drugs
4
drugs order
4
order rigidity
4
rigidity sugar
4
sugar moiety
4

Similar Publications

Large serine integrases (LSIs) catalyze unidirectional site-specific DNA recombination reactions, yet those reactions are reversed by the presence of a cognate recombination directionality factor (RDF). Mechanistic understanding of directionality control has been hampered by a lack of structural information. Here, we use cryo-electron microscopy (cryo-EM) to determine the structures of six SPbeta integrase-DNA complexes along the integrative (-RDF) and excisive (+RDF) reaction pathways, at 4.

View Article and Find Full Text PDF

Conformationally constrained nucleotides, LNA or α-L-LNA, at the 5' terminus of the antisense strand impeded gene silencing of small interfering RNA (siRNA) by hindering phosphorylation, thereby deterring loading into the RNA-induced silencing complex. Installation of a phosphate mimic, ()-vinyl phosphonate (VP), improved activity considerably. Gene silencing was more efficient when the antisense strand of the siRNA was modified with 5'-VP-α-L-LNA, which adopts a C3'- (south) conformation, than when the antisense strand was modified with 5'-VP-LNA, which adopts a C3'- (north) pucker.

View Article and Find Full Text PDF

A photoactivated chiral molecular clamp rotated by selective anion binding.

Chem Sci

August 2024

Key Laboratory of Colloid and Interface Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University Jinan 250100 People's Republic of China

Developing chiral molecular platforms that respond to external fields provides opportunities for designing smart chiroptical materials. Herein, we introduce a molecular clamp whose chiral properties can be turned on by photoactivation. Selective anion binding achieves rational tuning of the conformations and chiroptical properties of the clamp, including circular dichroism and circularly polarized luminescence.

View Article and Find Full Text PDF

The development of electrophilic ligands that rapidly modify specific lysine residues remains a major challenge. Salicylaldehyde-based inhibitors have been reported to form stable imine adducts with the catalytic lysine of protein kinases. However, the targeted lysine in these examples is buried in a hydrophobic environment.

View Article and Find Full Text PDF

Exploration of the polymorphic solid-state landscape of an amide-linked organic cage using computation and automation.

Chem Commun (Camb)

June 2024

Materials Innovation Factory and Department of Chemistry, University of Liverpool, 51 Oxford Street, Liverpool, L7 3NY, UK.

Organic cages can possess complex, functionalised cavities that make them promising candidates for synthetic enzyme mimics. Conformationally flexible, chemically robust structures are needed for adaptable guest binding and catalysis, but rapidly exchanging systems are difficult to resolve in solution. Here, we use low-cost calculations and high-throughput crystallisation to identify accessible conformers of a recently reported organic cage by 'locking' them in the solid state.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!